checkAd

     147  0 Kommentare Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes

    Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of $1.2 billion aggregate principal amount (the “Offering”) of the following notes:

    • $600 million aggregate principal amount of its 4.800% senior notes due 2027 (the “2027 notes”), at the issue price of 99.960% of their principal amount, and
    • $600 million aggregate principal amount of its 4.950% senior notes due 2032 (the “2032 notes” and together with the 2027 notes, the “notes”), at the issue price of 99.797% of their principal amount.

    The Offering is expected to close on or about November 21, 2022, subject to customary closing conditions. The notes will pay interest on a semi-annual basis.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Thermo Fisher Scientific!
    Long
    523,09€
    Basispreis
    5,56
    Ask
    × 8,94
    Hebel
    Short
    632,46€
    Basispreis
    0,56
    Ask
    × 8,73
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Thermo Fisher intends to use the net proceeds from the sale of the notes for general corporate purposes, which may include the acquisition of companies or businesses, repayment and refinancing of debt, working capital and capital expenditures or the repurchase of its outstanding equity securities or it may temporarily invest the net proceeds in short-term, liquid investments until they are used for their ultimate purpose.

    The joint book-running managers for the Offering are BofA Securities, Inc., Citigroup Global Markets Inc. and Deutsche Bank Securities Inc.

    The Offering is being made pursuant to an effective registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission (the “SEC”). Prospective investors should read the prospectus forming a part of that registration statement and the prospectus supplement related to the Offering and the other documents that Thermo Fisher has filed with the SEC for more complete information about Thermo Fisher and the Offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Thermo Fisher, the underwriters or any dealer participating in the Offering will arrange to send you the prospectus if you request it by calling BofA Securities, Inc. toll-free at 1-800-294-1322; Citigroup Global Markets Inc. toll-free at 1-800-831-9146; or Deutsche Bank Securities Inc. toll-free at 1-800-503-4611.

    Lesen Sie auch

    This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

    Seite 1 von 2


    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that on November 14, 2022 it priced an offering of $1.2 billion aggregate principal amount (the “Offering”) of the following notes: $600 million aggregate principal amount …

    Schreibe Deinen Kommentar

    Disclaimer